$CRMZ
CREDITRISKMONITOR COM INC

2020 Q4 Form 10-Q Financial Statement

#000114036120025168 Filed on November 10, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2020 Q2
Revenue $4.134M $4.037M $3.852M
YoY Change 9.82% 9.92% 7.97%
Cost Of Revenue $1.470M $1.515M $1.515M
YoY Change 1.88% 6.57% 6.24%
Gross Profit $2.664M $2.523M $2.337M
YoY Change 14.75% 12.03% 9.13%
Gross Profit Margin 64.44% 62.48% 60.66%
Selling, General & Admin $2.804M $2.110M $2.394M
YoY Change 35.49% 7.55% 11.48%
% of Gross Profit 105.26% 83.65% 102.47%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $59.11K $52.93K $53.70K
YoY Change 10.44% 0.49% 7.31%
% of Gross Profit 2.22% 2.1% 2.3%
Operating Expenses $2.863M $3.678M $3.963M
YoY Change 34.86% 7.04% 9.36%
Operating Profit -$199.3K $359.6K -$111.4K
YoY Change -200.47% 51.64% 96.36%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$240.00 $916.00 $3.417K
YoY Change -100.76% -97.72% -92.09%
Pretax Income -$199.6K $360.5K -$108.0K
YoY Change -186.8% 29.98% 697.99%
Income Tax -$40.50K $79.42K -$136.9K
% Of Pretax Income 22.03%
Net Earnings -$159.1K $281.1K $28.92K
YoY Change -198.2% 38.06% -350.83%
Net Earnings / Revenue -3.85% 6.96% 0.75%
Basic Earnings Per Share
Diluted Earnings Per Share -$14.84K $26.15K $2.697K
COMMON SHARES
Basic Shares Outstanding 10.72M 10.72M 10.72M
Diluted Shares Outstanding 10.75M

Balance Sheet

Concept 2020 Q4 2020 Q3 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.76M $10.45M $9.956M
YoY Change 30.03% 21.97% 18.47%
Cash & Equivalents $10.30M $10.45M $9.956M
Short-Term Investments $458.2K
Other Short-Term Assets $589.1K $596.6K $798.6K
YoY Change 7.14% 14.14% -4.12%
Inventory
Prepaid Expenses
Receivables $2.557M $1.945M $2.270M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $13.91M $12.99M $13.02M
YoY Change 25.14% 18.81% 16.65%
LONG-TERM ASSETS
Property, Plant & Equipment $545.7K $405.1K $439.3K
YoY Change 14.16% -21.32% -20.82%
Goodwill $1.954M $1.954M $1.954M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $84.89K $108.4K $33.45K
YoY Change 137.64% 122.87% 5.83%
Total Long-Term Assets $4.785M $4.714M $4.719M
YoY Change -1.32% -4.64% -5.82%
TOTAL ASSETS
Total Short-Term Assets $13.91M $12.99M $13.02M
Total Long-Term Assets $4.785M $4.714M $4.719M
Total Assets $18.69M $17.71M $17.74M
YoY Change 17.1% 11.51% 9.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $130.1K $47.54K $87.37K
YoY Change -5.39% 83.06% -30.96%
Accrued Expenses $1.822M $1.136M $1.278M
YoY Change 35.55% -8.0% 12.98%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.299M $1.103M $907.1K
YoY Change
Total Short-Term Liabilities $13.06M $11.63M $11.81M
YoY Change 27.03% 19.17% 15.1%
LONG-TERM LIABILITIES
Long-Term Debt $262.5K $458.7K $654.4K
YoY Change
Other Long-Term Liabilities $2.335M $2.369M $2.407M
YoY Change
Total Long-Term Liabilities $2.598M $2.827M $3.061M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $13.06M $11.63M $11.81M
Total Long-Term Liabilities $2.598M $2.827M $3.061M
Total Liabilities $15.99M $14.86M $15.19M
YoY Change 20.52% 15.85% 13.87%
SHAREHOLDERS EQUITY
Retained Earnings -$27.17M -$27.01M -$27.29M
YoY Change 0.17% 0.98% 1.26%
Common Stock $107.2K $107.2K $107.2K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.702M $2.848M $2.555M
YoY Change
Total Liabilities & Shareholders Equity $18.69M $17.71M $17.74M
YoY Change 17.1% 11.51% 9.69%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2020 Q2
OPERATING ACTIVITIES
Net Income -$159.1K $281.1K $28.92K
YoY Change -198.2% 38.06% -350.83%
Depreciation, Depletion And Amortization $59.11K $52.93K $53.70K
YoY Change 10.44% 0.49% 7.31%
Cash From Operating Activities $510.0K $514.3K $126.9K
YoY Change 96.01% 189.01% 48.54%
INVESTING ACTIVITIES
Capital Expenditures -$199.7K -$18.76K -$31.08K
YoY Change 1104.22% 46.91% -56.98%
Acquisitions
YoY Change
Other Investing Activities -$458.7K
YoY Change
Cash From Investing Activities -$658.4K -$18.76K -$31.08K
YoY Change 3871.05% 46.91% -56.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 1.562M
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 510.0K 514.3K 126.9K
Cash From Investing Activities -658.4K -18.76K -31.08K
Cash From Financing Activities 0.000 0.000 1.562M
Net Change In Cash -148.4K 495.5K 1.657M
YoY Change -49.26% 199.99% 12436.76%
FREE CASH FLOW
Cash From Operating Activities $510.0K $514.3K $126.9K
Capital Expenditures -$199.7K -$18.76K -$31.08K
Free Cash Flow $709.6K $533.0K $158.0K
YoY Change 156.41% 179.49% 0.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
47541
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
137500
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1945280
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2287921
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1344550
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1135506
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29705673
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29747939
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11810
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
40522
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
42266
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12465
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11810
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
40522
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12465
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
42266
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10451155
CY2020Q3 us-gaap Assets
Assets
17706917
CY2019Q4 us-gaap Assets
Assets
15962708
CY2019Q4 us-gaap Assets Current
AssetsCurrent
11113578
CY2020Q3 us-gaap Assets Current
AssetsCurrent
12992993
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8275836
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.01
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.03
us-gaap Depreciation And Amortization
DepreciationAndAmortization
153701
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
52931
CY2019Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
52667
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2175319
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
501451
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8275836
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8066899
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10451155
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8568350
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10722401
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10722401
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
32500000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
32500000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10722401
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10722401
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
107224
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
107224
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
397528
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
521765
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
74099
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-124237
CY2020Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
9189823
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
8651843
CY2019Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
166169
CY2020Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
188906
us-gaap Depreciation And Amortization
DepreciationAndAmortization
160736
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.01
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-89959
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-609260
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-342641
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-129771
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-209044
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-166409
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
560717
CY2019Q4 us-gaap Goodwill
Goodwill
1954460
CY2020Q3 us-gaap Goodwill
Goodwill
1954460
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11769
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
277357
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
113128
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
360502
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
73767
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-123424
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
79420
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
57536
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-39216
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
46737
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
13041
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
72714
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-68797
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
36533
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
106733
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
320200
CY2019Q3 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
0
CY2020Q3 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
295767
us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
98589
us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
33682
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15962708
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17706917
CY2019Q4 us-gaap Liabilities
Liabilities
13268489
CY2020Q3 us-gaap Liabilities
Liabilities
14858777
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
11633820
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10281122
CY2019Q4 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
0
CY2020Q3 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
1102833
CY2020Q3 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
458667
CY2019Q4 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
0
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
701713
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
626307
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
281082
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
203590
us-gaap Net Income Loss
NetIncomeLoss
55592
us-gaap Net Income Loss
NetIncomeLoss
111655
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-87894
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-124856
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1561500
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
124322
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
27017
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
916
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
40223
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4556456
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4316780
CY2019Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1421290
CY2020Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1514659
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2299433
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2179856
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
158117
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
147229
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
3436107
us-gaap Operating Expenses
OperatingExpenses
11636996
us-gaap Operating Expenses
OperatingExpenses
10747775
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
3677870
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2380974
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2245896
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
26389
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
31935
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
237134
us-gaap Operating Income Loss
OperatingIncomeLoss
-38786
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
359586
us-gaap Operating Income Loss
OperatingIncomeLoss
-11194
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
1561500
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
0
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
596558
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
549821
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35723
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
108437
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
87894
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
124856
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
405131
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
477973
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27118678
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27007023
us-gaap Revenues
Revenues
11598210
us-gaap Revenues
Revenues
10736581
CY2020Q3 us-gaap Revenues
Revenues
4037456
CY2019Q3 us-gaap Revenues
Revenues
3673241
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6919804
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2110280
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1962150
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6277294
us-gaap Share Based Compensation
ShareBasedCompensation
40522
us-gaap Share Based Compensation
ShareBasedCompensation
42266
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
2694219
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
2848140
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
2957832
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
2837891
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
2555248
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
3053946
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10722401
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10722401
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10722401
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10722401
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10725252
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10722401
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10730545
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10746834
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
CREDITRISKMONITOR COM INC
dei Entity Central Index Key
EntityCentralIndexKey
0000315958
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10722401
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Shell Company
EntityShellCompany
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
true

Files In Submission

Name View Source Status
0001140361-20-025168-index-headers.html Edgar Link pending
0001140361-20-025168-index.html Edgar Link pending
0001140361-20-025168.txt Edgar Link pending
0001140361-20-025168-xbrl.zip Edgar Link pending
brhc10016615_10q.htm Edgar Link pending
brhc10016615_ex31-1.htm Edgar Link pending
brhc10016615_ex31-2.htm Edgar Link pending
brhc10016615_ex32-1.htm Edgar Link pending
brhc10016615_ex32-2.htm Edgar Link pending
crmz-20200930.xml Edgar Link completed
crmz-20200930.xsd Edgar Link pending
crmz-20200930_cal.xml Edgar Link unprocessable
crmz-20200930_def.xml Edgar Link unprocessable
crmz-20200930_lab.xml Edgar Link unprocessable
crmz-20200930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending